Martin Dow products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Karachi · Pakistan
Core pharmaceutical entity of the Martin Dow Group, manufacturing and marketing branded generics and research-based products in Pakistan.
Martin Dow products in Pakistan
Martin Dow Limited has 237 medicine presentations registered in Pakistan under 70 brands, covering 61 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Endocrine & metabolic. Its brands with the most registered strengths and packs are Empator-M (Empagliflozin + Metformin), Elicia (Levetiracetam), Dowtel-AM (Telmisartan + Amlodipine) and Meblot (Ibuprofen). 237 products have an official DRAP price on MedInfoBase. See all 70 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- Nice Trade Orbit Building, Plot No. 44-A & B, PECHS Block VI, Shahrah-e-Faisal, Karachi, Pakistan
- Website
- martindowltd.com ↗
- Phone
- +92 21 111 111 634
- info@martindow.com
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Martin Dow Limited is priced against the market
225 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Veltezo | Bortezomib | 3.5 mg | Injection | 1's | 115769 | PKR 59,725.53 | PKR 59,725.53/vial/unit | 🔒 Pharma Pro |
| XALFOCIN | Cefixime | 400 mg | Capsule | 5's | 080646 | PKR 592.02 | PKR 118.40/capsule | 🔒 Pharma Pro |
| Xanilo DDR Capsule 30mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets eq. to Dexlansoprazole | — | — | — | 108828Official source ↗ | No indexed price | — | — |
| Xanilo DDR Capsule 60mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets eq. to Dexlansoprazole | — | — | — | 108829Official source ↗ | No indexed price | — | — |
| Xelcit | Clarithromycin | 250 mg/5 mL | Dry suspension | 60ml | 080648 | PKR 786.99 | PKR 13.12/mL | 🔒 Pharma Pro |
| XELCIT | Clarithromycin | 250 mg/5 mL | Dry suspension | 100ml | 080648 | PKR 1,245.52 | PKR 12.46/mL | 🔒 Pharma Pro |
| Xelcit | Clarithromycin | 125 mg/5 mL | Dry suspension | 60ml | 080649 | PKR 460.57 | PKR 7.68/mL | 🔒 Pharma Pro |
| Xelcit | Clarithromycin | 125 mg/5 mL | Dry suspension | 30ml | 080649 | PKR 227.19 | PKR 7.57/mL | 🔒 Pharma Pro |
| Xelcit | Clarithromycin | 250 mg | Tablet | 10's | 086023 | PKR 494.35 | PKR 49.44/tablet | 🔒 Pharma Pro |
| Xelcit | Clarithromycin | 500 mg | Tablet | 10's | 086024 | PKR 797.90 | PKR 79.79/tablet | 🔒 Pharma Pro |
| Xelcit | Clarithromycin | 500 mg | Tablet | 5's | 086025 | PKR 412.92 | PKR 82.58/tablet | 🔒 Pharma Pro |
All 70 Martin Dow brands in Pakistan
- ABICLOT Clopidogrel · 75 mg tablet
- ABICLOT PLUS Clopidogrel + Aspirin · 75 mg + 75 mg tablet
- Acti KI Potassium iodide · 130 mg tablet
- Amlesiv Amlodipine · 5 mg tablet
- Amlesive Amlodipine · 10 mg tablet
- Bactrim Sulfamethoxazole + Trimethoprim · 200 mg + 40 mg / 5 mL syrup, 400 mg + 80 mg tablet
- Bactrim Forte Sulfamethoxazole + Trimethoprim · 400 mg + 80 mg / 5 mL syrup, 800 mg + 160 mg tablet
- Caliana Clozapine · 100 mg tablet, 25 mg tablet
- CAMDROVA Bisoprolol fumarate · 10 mg tablet, 5 mg tablet
- Cef-Midox Ceftazidime · 1000 mg injection, 250 mg injection, 500 mg injection
- COLOSHYLD Lactulose · 3.35 g/5 mL syrup
- DEFMAT Cephalexin · 250 mg capsule, 500 mg capsule
- DORMICUM Midazolam · 7.5 mg tablet
- Dow-D Ampoules ( / ) Cholecalciferol · 5 mg/mL injection
- Dowdacla Daclatasvir · 30 mg tablet, 60 mg tablet
- DOWMOXI Moxifloxacin · 400 mg tablet
- DOWPHAGE Metformin · 1 g tablet, 250 mg tablet, 500 mg tablet
- Dowphage ER Metformin · 1000 mg tablet, 500 mg tablet, 750 mg tablet
- Dowtel-AM Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 5 mg tablet, 80 mg + 10 mg tablet
- Dowvent Inhalation Ipratropium bromide · 0.025 % solution
- Dowvir Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
- DOWZIN Zinc sulfate · 20 mg tablet
- Dowzinc Zinc sulfate monohydrate · 20 mg tablet
- Elicia Levetiracetam · 100 mg/mL solution, 1000 mg tablet, 250 mg tablet
- ELICIA ER Levetiracetam · 500 mg tablet, 750 mg tablet
- ELIXABAN Apixaban · 2.5 mg tablet, 5 mg tablet
- EMPATOR Empagliflozin · 10 mg tablet, 25 mg tablet
- Empator-M Empagliflozin + Metformin · 10 mg + 1000 mg tablet, 12.5 mg + 1000 mg tablet, 12.5 mg + 500 mg tablet
- EUARIA Dihydroartemisinin + Piperaquine · 40 mg + 320 mg capsule, 40 mg + 320 mg tablet
- FANSIDAR Sulfadoxine + Pyrimethamine · 500 mg + 25 mg tablet
- FANSIDAR PLUS Artesunate + Sulfadoxine + Pyrimethamine · 50 mg + 500 mg + 25 mg tablet
- FATRID Simvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Frolot Tenofovir disoproxil · 300 mg tablet
- FUVELOX Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Imadev s Imatinib · 100 mg tablet, 400 mg tablet
- Ismo Isosorbide dinitrate · 20 mg tablet
- Jython Linezolid · 100 mg/5 mL suspension, 200 mg/100 mL infusion, 400 mg tablet
- KINLEC Azithromycin · 200 mg/5 mL suspension
- Lebreta Letrozole · 2.5 mg tablet
- LINESTA Ciprofloxacin · 250 mg tablet, 250 mg/5 mL suspension, 500 mg tablet
- MABINAT Rivaroxaban · 10 mg tablet, 15 mg tablet, 20 mg tablet
- MALCIFER Iron polymaltose complex · 100 mg tablet, 100 mg elemental iron tablet, 50 mg/5 mL syrup
- MALCIFER-F Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet, 100 mg elemental iron + 0.35 mg folic acid tablet
- Meblot Ibuprofen · 100 mg/5 mL suspension, 200 mg tablet, 200 mg/5 mL suspension
- Miltocef Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- MOLTIQ Misoprostol · 100 mcg tablet, 200 mcg tablet
- New-Fort Cefotaxime · 250 mg injection
- New-Zone Ceftriaxone · 500 mg injection
- Norpro Metronidazole · 200 mg/5 mL suspension, 400 mg tablet
- Orzit Azithromycin · 250 mg tablet, 500 mg tablet
- OZBIR Sofosbuvir · 400 mg tablet
- Paclinab Paclitaxel · 100 mg injection
- Qudow Quetiapine · 100 mg tablet, 200 mg tablet, 25 mg tablet
- RIBUVIR Ribavirin · 400 mg tablet, 400 mg capsule, 500 mg tablet
- Rivelime Lenalidomide · 10 mg capsule, 25 mg capsule
- Rocephin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- SALVAJ Artemether + Lumefantrine · 20 mg + 120 mg tablet
- SALVAJ DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
- SALVAJ EEZ Artemether + Lumefantrine · 80 mg + 480 mg tablet
- SIEZIRA Divalproex sodium · 500 mg tablet
- Spiridow Tiotropium · 18 mcg capsule, 18 mcg inhalation
- Symbidow Budesonide + Formoterol · 200 mcg + 6 mcg inhalation, 400 mcg + 12 mcg inhalation
- Tarsinib Erlotinib · 100 mg tablet, 150 mg tablet
- Taztin Piperacillin + tazobactam · 2.25 g + 2 g injection, 4 g + 0.5 g injection
- TRAUN Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Valium Diazepam · 10 mg tablet, 2 mg tablet, 5 mg tablet
- Velmon-H Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet, 80 mg + 25 mg tablet
- Veltezo Bortezomib · 3.5 mg injection
- XALFOCIN Cefixime · 400 mg capsule
- Xelcit Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
Martin Dow: common questions
How many products does Martin Dow have in Pakistan?
Martin Dow Limited has 237 registered medicine presentations in Pakistan, sold under 70 brands and covering 61 generic medicines.
What are the main brands of Martin Dow?
By number of registered strengths and packs, its largest brands are Empator-M (Empagliflozin + Metformin), Elicia (Levetiracetam), Dowtel-AM (Telmisartan + Amlodipine), Meblot (Ibuprofen) and RIBUVIR (Ribavirin). This is not a sales ranking.
Which therapy areas does Martin Dow cover?
The most products are in Anti-infectives (77), CNS & mental health (38), Endocrine & metabolic (37), Cardiovascular (25) and Oncology & immunology (15).
Where can I see Martin Dow medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.